Cyient DLM Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/pjlnw7bjcmwuupxyhqd69fwy.pdf

Key Takeaways


The Order Book & Revenue Visibility

Subramanian: "The aerospace business is a double-edged sword. It's very, very difficult to get into. But once you are in you're in. And we are fortunate that we're pretty much in with every single major OEM or significant Tier 1 that buys any electronics."

Aerospace & Defence: The Moat Business

Subramanian: "Look at the data centre business, the reality of that is it is up now. It will go down that's just how some of these technology-related businesses work. But aerospace, what really differentiates us a strong aerospace capability because that's a moat that's impossible to or it's very, very difficult to reach for a new entrant, and we're in the moat and we're very strongly placed in the moat."

Margin Profile & Cash Flow Dynamics

Rajendra Velagapudi: "We have to stock enough to make sure during this difficult time, our revenue is not impacted in any way. And we are happy to say that that is something which we have been able to achieve as you can in the results, okay? So as long as we have this growth, these investments which we need to do it. But once we have the growth and the inventory coming under control, which we are working on, the cash flow will turn positive, and that is what we are all working towards."

New Growth Vectors: B2S, AI Data Centres & Robotics

Rajendra Velagapudi: "I think we just started this thing. We have our sales directors on board in this quarter. I think we will be probably giving some updates in the next 1 or 2 quarters about where we are focusing and where are we today in terms of our momentum in AI and data centers."

Strategic Roadmap: The SET Framework

Rajendra Velagapudi: "The through line of this slide is a deliberate progression: widen the industries we serve and steadily elevate the value we deliver, moving up the margin curve at each stage."

Segment & Regional Dynamics

SegmentRevenue ShareYoY GrowthCommentary
Aerospace42%▲ 40%Strong, durable moat; Honeywell ramp and Thales growth ahead.
Industrial32%▲ 90%Largest growth contributor alongside aerospace.
Defence9%▲ 35%ITAR facility active; US and European defence pipelines building.
MedTech—▬ FlatFlat YoY due to seasonal impact from one customer; pipeline available, no concern.
Rajendra Velagapudi: "What we are seeing even now today is there is -- there are some delays in the logistics in terms of shipments and we are also seeing some of the costs going up due to these West Asia crisis at this point of time. But we are already well planned in terms of our execution, so we have not seen any of those challenges in Q1 and we also just put a plan together to ensure that those things won't impact much in Q2."

Guidance & Commitments

CommitmentSpecificsTimeline
Book-to-bill ratioMaintain 1.5x for the full yearFY27
Revenue and order momentumSimilar momentum expected; no major concernQ2 and beyond
EBITDA margin expansionMove to 11%–13% via new industries (AI data centres, robotics, semiconductor capital equipment)FY27–FY29
B2S meaningful revenueSubstantial revenues expected; will add 250–300 bps to consolidated EBITDA marginNext 1–18 months
Honeywell Aerospace ramp-upBig growth expected as initial builds rampNext 18 months
SkyDrive production lineProduction line expectedNext 1–1.5 years
AI data centre and robotics product-line detailsDisclosure of focus areas and product linesNext 2–3 quarters
Cash flowTurn positive once growth stabilizes and inventory comes under controlNo date (condition-based)

Key Metrics

MetricQ1 FY27
Revenue₹373.8 cr, +34.3% YoY
EBITDA₹39.2 cr, +56.2% YoY
EBITDA margin10.5%, +147 bps YoY; fourth consecutive quarter of double-digit margins
PAT₹16.3 cr, +118.2% YoY
PAT margin4.4%, +168 bps YoY
Finance costs-29% YoY, driven by lower working capital borrowings
Order book₹2,598.9 cr, highest in company history; +₹183.2 cr QoQ
Order intake₹551.9 cr
Book-to-bill ratio1.5x, expected to sustain for FY27
Aerospace revenue share42% of revenue, +40% YoY
Industrial revenue share32% of revenue, +90% YoY
Defence revenue share9% of revenue, +35% YoY
MedTech revenue share16% of revenue, broadly flat YoY
PCBA revenue share48% of revenue, +21% YoY
Box build revenue share21% of revenue, +85% YoY
Inventory days162 days, vs 153 days in Q4 FY26
Net working capital days161 days, vs 145 days in Q4 FY26
DSO77 days, vs 74 days in Q4 FY26